Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience Inks Asian Distribution Deals

NEW YORK (GenomeWeb) – Twist Bioscience announced today that it has signed distribution deals for its synthetic DNA and next-generation sequencing products in various Asian markets.

According to Twist, it has selected Recenttec KK as its distribution partner in Japan; DNA Link subsidiary LnCBio in Korea; Premas Life Sciences in India; and BioArrow Technology in Hong Kong and Macau. The deals cover Twist's gene, gene fragment, and oligo pool product lines, as well as its newly launched exome and custom target enrichment product line for NGS.

"Building on our solid foundation in the United States and Europe, we are extending our global footprint by leveraging selected distributors with strong commercial presence and deep ties to our potential customers in these important geographies," Twist CEO Emily Leproust said in a statement.

Earlier this month, Twist closed a $50 million private placement.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.